Wahrnehmung der COVID-19-Pandemie unter pneumologischen Fachkräften in Deutschland

Teleconsultation in respiratory medicine - A position paper of the Portuguese Pulmonology Society

The COVID-19 pandemic crisis, among so many social, economic and health problems, also brought new opportunities. The potential of telemedicine to improve health outcomes had already been recognised in the last decades, but the pandemic crisis has accelerated the digital revolution. In 2020, a rapid increase in the use of remote consultations occurred due to the need to reduce attendance and overcrowding in outpatient clinics. However, the benefit of their use extends beyond the pandemic crisis, as an important tool to improve both the efficiency and capacity of future healthcare systems. This article reviews the literature regarding telemedicine and teleconsultation standards and recommendations, collects opinions of Portuguese experts in respiratory medicine and provides guidance in teleconsultation practices for Pulmonologists.

Allergen immunotherapy during the COVID-19 pandemic-A survey of the German Society for Allergy and Clinical Immunology

Background

When the coronavirus pandemic 2019 (COVID‐19) emerged, concerns were also raised regarding the safety of allergen immunotherapy (AIT). The German Society for Allergology and Clinical Immunology (DGAKI) conducted a survey to collect real‐world data on the daily routine of administering subcutaneous AIT (SCIT) and sublingual AIT (SLIT) during the COVID‐19 pandemic.

Methods

A web‐based retrospective survey using the online platform survio with 26 standardized questions was used to survey physicians treating allergic patients during the pandemic.

Results

Three hundred and forty‐five physicians who regularly offer and perform AIT in German‐speaking countries responded to the questions. 70.4% of the respondents stated that they regularly initiated and dosed up SCIT for inhalant allergies (41.4% venom‐SCIT, 73.6% SLIT), and 85.2% of the respondents stated that they continued SCIT for inhalant allergies during the maintenance phase in a regular way (59.1% venom‐SCIT, 90.4% SLIT) in healthy patients without current symptoms indicating an infection with COVID‐19. With regard to tolerability, there was no evidence for increased occurrence of adverse events in patients without current symptoms of COVID‐19 infection during the pandemic.

Conclusions

This retrospective study demonstrated adherence to national and international position papers of AIT during the COVID‐19 pandemic in German‐speaking countries. Besides, the survey has confirmed a good tolerability of AIT for both SCIT and SLIT.

[COVID-19 and Anxiety Amongst General Practitioners, Psychiatrists and Surgeons - A German Perspective]

OBJECTIVE

The COVID-19 pandemic represents an exceptional challenge for the medical fraternity. We examined the differences in experiencing anxiety of general practitioners (GP), psychiatrists (PS) and surgeons (SU) during the COVID-19 pandemic in Germany.

METHODS

E-mail-based survey (April-May 2020) of 608 physicians (GP n = 162, PS n = 299, SU n = 147) on anxiety experience in relation to COVID-19 and potential determinants.

RESULTS

High levels of COVID-19-related anxiety were reported by 31.1 % of GP, 19.2 % of PS, and 11.6 % of SU. The frequency of contact with COVID-19 patients was highest in SU (68.5 %), followed by GP (51.0 %) and PS (8.1 %). The experience of COVID-19-related distress was overall highest among GP. SU felt best informed and rated their resilience most highly. A high level of anxiety was positively associated with the perceived risk of infection.

CONCLUSION

Studies on the distress of physicians provide important information to optimize pandemic management.